Prostate Cancer Clinical Consortium Clinical Research Site: Targeted Therapies

reportActive / Technical Report | Accesssion Number: AD1047899 | Open PDF

Abstract:

The Weill Cornell Medical College Prostate Cancer Research Program (WCMC-PCRP) is a Clinical Research Site of the Prostate Cancer Clinical Trials Consortium (PCCTC). The purpose of the research is to lead and participle in Consortium therapeutic and correlative science research protocols. Specifically, our aims are to impact prostate cancer care and outcomes through the development and study of novel targeted therapeutics, discovery of mechanisms of therapy resistance/sensitivity, identification of new therapeutic targets through high quality genomic analyses, providing access to the highest quality PC tissue specimens, and development of molecular imaging techniques with direct relevance to targeted therapies. Our overarching goal is to more effectively bring novel agents and new biomarker driven trials directly to patients.

Author(s):
Nanus, David
Author Organization(s):
Weill Medical College of Cornell University
Funding Organization(s):
Publication Date:
2017 Oct 01
Pagination:
0

Security Markings

RECORD

Collection: TRECMS
Subject Terms
Modernization Areas:
Biotechnology
Communities of Interest:
No COI(s) Identified
Descriptor(s):
health services, medical personnel, oncology, genetics, therapy, androgen receptors, data analysis, disease attributes, imaging techniques, institutional review board, cancer, biomedical research, diseases and disorders, hematologic diseases, androgens, demographic cohorts, electronic mail
Keyword(s):
wcmc-pcrp (Weill Cornell Medical College Prostate Cancer Research Program), Clinical Research Sites, pccctc (Prostate Cancer Clinical Trials Consortium), molecular imaging, aurora kinase A, circulating tumor cells, monoclonal antibodies, nepc (neuroendocrine prostate cancer), next-generation sequencing, prostate specific membrane antigen, translational research program
Subject Categories:
Biological and Medical Sciences
Update Date:
2018 Mar 09